Advertisement

Cell monitoring with optical coherence tomography

Published:October 20, 2022DOI:https://doi.org/10.1016/j.jcyt.2022.09.008

      Abstract

      Background aims

      We evaluated a commercially available instrument, OCTiCell (chromologic.com/octicell), for monitoring cell growth in suspended agitated bioreactors based on optical coherence tomography. OCTiCell is an in-line, completely non-invasive instrument that can operate on any suspended-cell bioreactor with a window or transparent wall. In traditional optical coherence tomography, the imaging beam is rastered over the sample to form a three-dimensional image. OCTiCell, instead uses a fixed imaging beam and takes advantage of the motion of the media to move the cells across the interrogating optical beam.

      Results

      We found strong correlations between the non-invasive, non-contact, reagent-free OCTiCell measurements of cell concentration and viability and those obtained from the automated cell counter, and the XTT viability assay, which is a colorimetric assay for quantifying metabolic activity.

      Conclusions

      This novel cell monitoring method can adapt to different bioreactor form factors and could reduce the labor cost and contamination risks associated with cell growth monitoring.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Makurvet F.D.
        Biologics vs. small molecules: Drug costs and patient access.
        Med. Drug Discov. 2021; 9100075
        • Nath S.C.
        • Harper L.
        • Rancourt D.E.
        Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance.
        Front. Bioeng. Biotechnol. 2020; 8: 1-16
        • Reddy O.L.
        • Stroncek D.F.
        • Panch S.R.
        Improving CAR T cell therapy by optimizing critical quality attributes.
        Semin. Hematol. 2020; 57: 33-38
        • Butler M.
        • Spearman M.
        • Braasch K.
        Monitoring cell growth, viability, and apoptosis.
        Methods Mol. Biol. 2014; 1104: 169-192
        • O'Mara P.
        • Farrell A.
        • Bones J.
        • Twomey K.
        Staying alive! Sensors used for monitoring cell health in bioreactors.
        Talanta. 2018; 176: 130-139
        • Arora M.
        Cell Culture Media: A Review.
        Mater. Methods. 2013; 3: 1-29
        • Eibl R.
        • Kaiser S.
        • Lombriser R.
        • Eibl D.
        Disposable bioreactors: The current state-of-the-art and recommended applications in biotechnology.
        Appl. Microbiol. Biotechnol. 2010; 86: 41-49
        • Metze S.
        • Ruhl S.
        • Greller G.
        • Grimm C.
        • Scholz J
        Monitoring online biomass with a capacitance sensor during scale-up of industrially relevant CHO cell culture fed-batch processes in single-use bioreactors.
        Bioprocess Biosyst. Eng. 2020; 43: 193-205
        • Kiviharju K.
        • et al.
        On-line biomass measurements in bioreactor cultivations: Comparison study of two on-line probes.
        J. Ind. Microbiol. Biotechnol. 2007; 34: 561-566
        • Abu-Absi N.R.
        • et al.
        Real time monitoring of multiple parameters in mammalian cell culture bioreactors using an in-line Raman spectroscopy probe.
        Biotechnol. Bioeng. 2011; 108: 1215-1221
        • Schmitt J.M.
        Optical Coherence Tomography (OCT): a review.
        IEEE J. Sel. Top. Quantum Electron. 1999; 5: 1205-1215
      1. Tashman, J. W. et al. In Situ Volumetric Imaging and Analysis of FRESH 3D Bioprinted Constructs Using Optical Coherence Tomography. bioRxiv 2021.06.30.450389 (2021).

        • Roberge C.L.
        • et al.
        Non-Destructive Tumor Aggregate Morphology and Viability Quantification at Cellular Resolution, During Development and in Response to Drug.
        Acta Biomater. 2020; 117: 322-334
        • Dunkers J.P.
        • Lee Y.J.
        • Chatterjee K.
        Single cell viability measurements in 3D scaffolds using in situ label free imaging by optical coherence microscopy.
        Biomaterials. 2012; 33: 2119-2126
        • Yang L.
        • Yu X.
        • Fuller A.M.
        • Troester M.A.
        • Oldenburg A.L
        Characterizing optical coherence tomography speckle fluctuation spectra of mammary organoids during suppression of intracellular motility.
        Quant. Imaging Med. Surg. 2020; 10: 76-85
        • Jeong K.
        • Turek J.J.
        • Nolte D.D.
        Volumetric motility-contrast imaging of tissue response to cytoskeletal anti-cancer drugs.
        Opt. Express. 2007; 15: 14057
        • Lee J.S.
        • Eom K.
        • Polucha C.
        • Lee J.
        Standard-unit measurement of cellular viability using dynamic light scattering optical coherence microscopy.
        Biomed. Opt. Express. 2018; 9: 5227
        • Farhat G.
        • Yang V.X.D.
        • Czarnota G.J.
        • Kolios M.C
        Detecting cell death with optical coherence tomography and envelope statistics.
        J. Biomed. Opt. 2011; 16026017
        • Hacker G.
        The morphology of apoptosis. Cell Tissue Res.
        Cell Tissue Res. 2000; 301: 5-17
        • Kamiloglu S.
        • Sari G.
        • Ozdal T.
        • Capanoglu E
        Guidelines for cell viability assays.
        Food Front. 2020; 1: 332-349
        • Cleveland W.S.
        Robust locally weighted regression and smoothing scatterplots.
        J. Am. Stat. Assoc. 1979; 74: 829-836
        • Clincke M.-F.
        • et al.
        Study of a recombinant CHO cell line producing a monoclonal antibody by ATF or TFF external filter perfusion in a WAVE BioreactorTM.
        BMC Proc. 2011; 5: 9-11